Concepedia

Actionable Mutation Reporting

Actionable Mutation Reporting is a genomic data interpretation framework that identifies and communicates clinically significant somatic alterations in cancer genomes to guide targeted therapeutic interventions.

14

Publications

452

Citations

168

Authors

57

Institutions

Publications per year

2017–2026

8

Parents

Publications

14

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

Filip Jankú, Philipp Angenendt, Apostolia M. Tsimberidou et al. · Oncotarget · 2015 · 93 citations · Full text

, , +11

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

Júlia Perera‐Bel, Barbara Hutter, Christoph Heining et al. · Genome Medicine · 2018 · 60 citations · Full text

, , +17

Racial Diversity of Actionable Mutations in Non–Small Cell Lung Cancer

Aliccia Bollig‐Fischer, Wei Chen, Shirish M. Gadgeel et al. · Journal of Thoracic Oncology · 2014 · 56 citations · Full text

, , +14

Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non–Small-Cell Lung Cancer With Rare or Complex Mutational Profiles

Bart Koopman, Anthonie J. van der Wekken, Arja ter Elst et al. · JCO Precision Oncology · 2020 · 48 citations · Full text

, , +17

Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors

Guruprasad Ananda, Susan M. Mockus, Micaela Lundquist et al. · Experimental and Molecular Pathology · 2015 · 34 citations · Full text

, , +16

1–5 of 14

Authors

168

  1. KK
    Kathleen Kerrigan

    Flatiron Health (United States), United States

    1 publications · 27 citations

    1

    h-index

  2. FF
    Florinda Feroce

    University of Campania "Luigi Vanvitelli", Italy

    1 publications · 27 citations

    1

    h-index

  3. QH
    Qiangze Hoi

    National University of Singapore, Singapore

    1 publications · 12 citations

    1

    h-index

  4. SE
    Seow Eng Lee

    National University Cancer Institute, Singapore, Singapore

    1 publications · 12 citations

    1

    h-index

  5. GZ
    Gord Zhu

    Cooper Medical School of Rowan University, United States

    1 publications · 13 citations

    1

    h-index

1–5 of 168

Institutions

57

  1. South China University of Technology

    Guangzhou, China

    1 h-index

    7 publications

    84 citations

  2. University of Chicago

    Chicago, United States

    1 h-index

    6 publications

    144 citations

  3. Singapore General Hospital

    Singapore, Singapore

    1 h-index

    2 publications

    24 citations

  4. Istituto Dermopatico dell'Immacolata

    Rome, Italy

    1 h-index

    1 publications

    27 citations

  5. University Hospital Carl Gustav Carus

    Dresden, Germany

    1 h-index

    1 publications

    60 citations

  6. National Center for Tumor Diseases

    Heidelberg, Germany

    1 h-index

    5 publications

    300 citations

  7. University Medical Center Groningen

    Groningen, The Netherlands

    1 h-index

    11 publications

    528 citations

  8. University of Groningen

    Groningen, The Netherlands

    1 h-index

    13 publications

    624 citations

1–8 of 57

Venues

  1. JCO Precision Oncology

    2 publications · 62 citations

    2

    h-index

  2. Oncotarget

    2 publications · 117 citations

    2

    h-index

  3. Molecular and Clinical Oncology

    1 publications · 12 citations

    1

    h-index

  4. Genome Medicine

    1 publications · 60 citations

    1

    h-index

  5. European Journal of Cancer

    1 publications · 27 citations

    1

    h-index

1–5